% | $
Quotes you view appear here for quick access.

Oculus Innovative Sciences, Inc. Message Board

  • ikabro ikabro Feb 7, 2012 7:53 PM Flag

    Conference Call - Diabetes Part!

    "So, we have most recently in-licensed and we formulated a unique compound for pre-diabetic and diabetic patients to safely stabilize their glucose and assist in weight loss.This is an oral or systemic compound with more than 500,000 patient studies in a retrospective study that was conducted.
    It will be marketed as an Rx product and it is ready to be marketed from a regulatory point of view.
    Our facility has also undergone through a whole new rigorous revamp in order to meet the FDA standards for production of such compound, and we have successfully passed this inspection by state, FDA, and cleared our production for this new product immediately. So, we hope to finalize a partner in this arena as early as this year. Again, I'll point out that we are looking at both internationally as well as domestically.

    So, just to give you a data point what we're looking at in terms of this compound and the market as it compares to Microcyn. According to the research organization, [Net Market Diligence] the US market for product in the management of diabetes represents roughly around 38% of a $41 billion global annual marketing (inaudible). So, this is a significant market. But more importantly, our compound is not only helping in stabilizing the glucose but also allowed for weight loss, which is very key for diabetes patients. And most of us, if not all, know at least one friend or loved one that has been touched by this disorder."

    SortNewest  |  Oldest  |  Most Replied Expand all replies
4.59-0.03(-0.65%)Jul 26 3:57 PMEDT